Treatment Considerations for Patients With Comorbid Thyroid Dysfunction and Diabetes
Disorders of thyroid function are common in type 1 and type 2 diabetes, and a growing number of cases of subclinical hypothyroidism are being detected.
Type 2 Diabetes
Smartphone Apps for T2D Self-Management Lack Decision Support, Patient Education
Few smartphone apps for self-management of type 2 diabetes provide sufficient real-time action prompts or education on blood glucose monitoring.
Cardiovascular Effects of Canagliflozin Vary According to Concomitant Metformin Use
The cardiovascular and renal effects of treatment with canagliflozin in patients with type 2 diabetes are more prominent in patients not taking metformin compared with patients treated with canagliflozin as an add-on to metformin.
Novel Cardiometabolic Staging Tool Predicts T2D Risk in Diverse Population
A weighted cardiometabolic disease staging risk score can be used to quantify race- and sex-specific type 2 diabetes risk in a large, diverse population.
Abaloparatide Followed by Alendronate Shows Promising Results for Women With Osteoporosis, T2D
Abaloparatide followed by alendronate treatment may improve bone mineral density in women with postmenopausal osteoporosis and type 2 diabetes.
Linagliptin Does Not Increase Adverse Renal Events in Patients With T2D, Kidney Disease
Treatment with linagliptin in patients with type 2 diabetes and cardiovascular and/or kidney disease had no impact on risk for cardiovascular or kidney events.
Type 2 Diabetes Associated With Short-Term Risk for Fracture
Type 2 diabetes is associated with increased risk for fractures in the short term but not in the long term.
Atrasentan Associated With Lower Risk for Kidney Events in T2D With CKD
Atrasentan is associated with a reduced risk for renal events in patients with type 2 diabetes and chronic kidney disease.
Evolocumab Effective, Well Tolerated in Patients With Type 2 Diabetes Receiving Statin Therapy
The addition of monthly evolocumab to statin therapy for individuals with hypercholesterolemia or mixed dyslipidemia and type 2 diabetes led to significant reductions in low-density lipoprotein cholesterol.
ADA Updates Consensus Report Regarding Personalized Nutrition Therapy in Type 2 Diabetes
There is no single recommended nutrition plan for all people with diabetes given the broad spectrum of people affected by diabetes and prediabetes.
Next post in Type 2 Diabetes
